Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-24.71 Insider Own2.30% Shs Outstand0.94M Perf Week1.11%
Market Cap4.27M Forward P/E- EPS next Y-8.81 Insider Trans148.01% Shs Float0.91M Perf Month1.11%
Income-13.50M PEG- EPS next Q-2.93 Inst Own6.62% Short Float2.61% Perf Quarter3.65%
Sales0.00M P/S- EPS this Y56.83% Inst Trans- Short Ratio0.02 Perf Half Y-42.98%
Book/sh11.82 P/B0.38 EPS next Y24.41% ROA-96.75% Short Interest0.02M Perf Year-86.05%
Cash/sh12.00 P/C0.38 EPS next 5Y- ROE-113.42% 52W Range3.82 - 36.60 Perf YTD-48.70%
Dividend Est.- P/FCF- EPS past 5Y75.28% ROI-133.40% 52W High-87.60% Beta1.37
Dividend TTM- Quick Ratio4.84 Sales past 5Y-38.82% Gross Margin78.40% 52W Low18.85% ATR (14)0.34
Dividend Ex-Date- Current Ratio4.84 EPS Y/Y TTM86.01% Oper. Margin0.00% RSI (14)45.74 Volatility7.20% 6.39%
Employees9 Debt/Eq0.02 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price33.75
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q43.55% Payout- Rel Volume0.03 Prev Close4.49
Sales Surprise- EPS Surprise-22.40% Sales Q/Q-100.00% EarningsMay 14 BMO Avg Volume1.14M Price4.54
SMA20-0.06% SMA50-14.33% SMA200-35.01% Trades Volume31,897 Change1.11%
Jul-11-24 08:00AM
Jun-24-24 09:00AM
Jun-21-24 08:15AM
Jun-17-24 08:00AM
Jun-14-24 09:55AM
08:30AM Loading…
Jun-11-24 08:30AM
Jun-10-24 09:15AM
May-21-24 08:30AM
May-14-24 08:05AM
May-13-24 10:53PM
May-07-24 08:30AM
May-02-24 08:30AM
May-01-24 08:30AM
08:30AM Loading…
Apr-23-24 08:30AM
Apr-16-24 11:22AM
Apr-11-24 09:15AM
Apr-10-24 08:15AM
Apr-03-24 05:30PM
Mar-27-24 08:00AM
Mar-26-24 11:52PM
Feb-15-24 08:35AM
Feb-13-24 08:35AM
Feb-08-24 02:40PM
Jan-30-24 09:25AM
Jan-29-24 02:01PM
08:00AM Loading…
Jan-09-24 08:00AM
Dec-29-23 04:52AM
Dec-28-23 08:00AM
Nov-10-23 08:05AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Sep-14-23 07:13PM
Sep-11-23 04:01PM
Sep-07-23 08:30AM
Sep-06-23 08:45AM
Aug-11-23 08:05AM
Aug-09-23 08:05AM
Jul-05-23 08:45AM
Jun-22-23 08:30AM
Jun-14-23 08:45AM
Jun-01-23 08:45AM
May-24-23 08:45AM
May-17-23 08:30AM
May-12-23 08:05AM
May-11-23 09:05AM
Apr-06-23 09:00AM
Apr-05-23 08:35AM
Apr-04-23 08:30AM
Apr-03-23 08:30AM
Mar-23-23 08:05AM
Mar-15-23 08:30AM
Mar-01-23 09:05AM
Feb-08-23 08:35AM
Jan-11-23 01:00PM
Jan-10-23 08:35AM
Jan-09-23 08:45AM
Jan-04-23 05:15PM
Dec-30-22 08:45AM
Dec-16-22 08:05AM
Dec-07-22 08:35AM
Dec-01-22 02:44PM
Nov-22-22 08:35AM
Nov-18-22 08:05AM
Nov-17-22 08:30AM
Nov-15-22 11:15AM
Nov-14-22 08:45AM
Oct-11-22 09:25AM
Sep-29-22 08:35AM
Sep-23-22 04:30PM
Sep-21-22 09:23AM
Sep-15-22 08:30AM
Sep-13-22 09:05AM
Aug-17-22 08:35AM
Aug-16-22 04:05PM
Aug-15-22 09:00AM
Aug-12-22 08:30AM
Aug-01-22 08:05AM
Jul-27-22 08:05AM
Jun-29-22 08:30AM
Jun-07-22 08:30AM
May-13-22 09:00AM
May-10-22 05:00PM
May-06-22 08:30AM
May-05-22 08:30AM
May-02-22 08:35AM
Apr-29-22 08:05AM
Mar-30-22 03:47PM
Mar-24-22 08:30AM
Mar-22-22 08:30AM
Mar-18-22 08:30AM
Mar-16-22 08:00AM
Mar-14-22 09:15AM
Mar-09-22 08:30AM
Feb-18-22 08:30AM
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wei BinxianDirectorJun 11 '24Option Exercise0.004650467Jun 12 09:41 PM
Williams Donald AllenDirectorJun 11 '24Option Exercise0.003400340Jun 12 09:40 PM
Finley John DavidCEO, CFO, DirectorMay 28 '24Option Exercise0.007,068014,079May 30 07:44 PM
Jones Mitchell LawrenceChief Medical OfficerMay 28 '24Option Exercise0.004,29004,313May 30 07:44 PM
Williams Donald AllenDirectorMay 28 '24Buy4.861,0004,8631,000May 29 03:47 PM
Finley John DavidCEO, CFO, DirectorMay 24 '24Buy4.811,0004,8108,437May 28 06:02 AM
Jones Mitchell LawrenceCEO, CFO, DirectorMay 06 '24Option Exercise0.004600880May 08 06:37 PM
Finley John DavidCEO, CFO, DirectorMay 06 '24Option Exercise0.0044306,832May 08 06:36 PM
Finley John DavidCEO, CFO, DirectorMar 11 '24Option Exercise0.005,558096,849Mar 12 06:29 PM
Neal James RDirectorFeb 09 '24Option Exercise0.0010,920010,920Feb 13 03:08 PM
Trenschel Robert J.DirectorFeb 08 '24Option Exercise0.0010,920010,920Feb 13 03:08 PM
Csimma CristinaDirectorFeb 08 '24Option Exercise0.0012,800012,862Feb 13 03:08 PM
Diaz StephanieDirectorFeb 08 '24Option Exercise0.0012,800012,800Feb 13 03:08 PM
Finley John DavidCEO, CFO, DirectorFeb 06 '24Option Exercise0.006,642091,291Feb 08 04:37 PM
Jones Mitchell LawrenceChief Medical OfficerFeb 06 '24Option Exercise0.006,89109,815Feb 08 04:38 PM
Finley John DavidCEO, CFO, DirectorFeb 06 '24Buy0.4710,0004,69284,649Feb 07 08:30 AM
Williams Donald AllenDirectorJan 31 '24Buy0.6010,0006,05030,000Feb 01 08:30 AM
Finley John DavidCEO, CFO, DirectorJan 31 '24Buy0.5610,0005,59074,649Feb 01 08:30 AM
Finley John DavidCEO, CFO, DirectorJan 03 '24Option Exercise0.001,309064,649Jan 05 04:00 PM
Finley John DavidCEO, CFO, DirectorDec 11 '23Option Exercise0.005,559063,340Dec 19 05:57 PM
Finley John DavidCEO, CFO, DirectorNov 06 '23Option Exercise0.003,475047,781Nov 08 05:01 PM
Jones Mitchell LawrenceChief Medical OfficerNov 06 '23Option Exercise0.004,55604,556Nov 08 05:01 PM
Finley John DavidCEO, CFO, DirectorOct 03 '23Option Exercise0.001,309044,703Oct 05 05:46 PM
Williams Donald AllenDirectorSep 27 '23Buy0.5420,00010,80020,000Sep 29 09:25 AM
Finley John DavidCEO, CFO, DirectorSep 27 '23Buy0.5415,0008,08843,394Sep 29 09:21 AM
Trenschel Robert J.DirectorSep 14 '23Sale0.643001920Sep 15 05:15 PM
Finley John DavidCEO, CFO, DirectorSep 13 '23Buy0.6615,0009,82528,394Sep 14 05:00 PM
Finley John DavidCEO, CFO, DirectorSep 11 '23Option Exercise0.005,558015,186Sep 13 04:55 PM
Finley John DavidCEO, CFO, DirectorAug 06 '23Option Exercise0.003,475011,057Aug 14 06:33 PM